Taller People Have Augmented Menace For Developing Atrial Fibrillation

Taller People Have Augmented Menace For Developing Atrial Fibrillation

As per a new Penn Medicine study, taller people have amplified perils of developing AFib (atrial fibrillation). AFib is an irregular and mostly rapid heartbeat that can cause heart failure, stroke, and other problems. The research—which discloses a strong association amid the genetic variants linked with height and one’s menace for AFib—is amongst the first to show that height might be a causal risk aspect for AFib. The study findings were presented at the AHA’s (American Heart Association) 2019 Scientific Sessions in Philadelphia. The scientists discovered that the risk for AFib surged as one’s height increased, with every 1-Inch increase in height showed about 3% augment in risk of AFib—autonomous of other clinical aspects—as correlated to those at average height (5 Feet and 7 Inches).

Michael Levin—Lead Author of the study—said, “Our findings indicated that it might be helpful to incorporate height in risk-forecast tools for AFib. While present guidelines recommend against prevalent screening for AFib, the study findings showed that a particular group of patients—particularly tall patients—might benefit from screening.” Reportedly, AFib impacts over 33 Million people globally and is an ordinary and abnormal heart rhythm. There are many clinical risk aspects for advancing AFib—counting high blood pressure, diabetes, heart disease, and obesity. The analysis disclosed that genetic variants linked with height were robustly connected with AFib, hinting that increased height could be a cause of AFib.

On a related note, recently, a study showed that AFib is a common and incurable condition but can be controlled. Almost 6 Million people across the U.S. and 33 Million people globally have AFib and the exact reason for which is unknown. As people age, they are more inclined to have AFib. The mainstream theory is that age-related modifications in the heart—tissue changes known as fibrosis—form the arrhythmia. Dr. Christopher Rogers—Cardiologist at Penn State Health Medical Group—said, “I see at AFib as an iceberg. We just know the small part above it, but the larger part is yet to understand.”

Samantha Meyer
Contributor At Times of Market

With a prodigious 5 years of experience in the Health sector, Samantha serves as the Head of Health Section of Times Of Market. Samantha has completed the Doctor of Medicine Degree and is actively involved in the administrative work of Times Of Market. She holds exceptional command over writing news reports on various health-related topics. Moreover, carrying out the quality check of all news reports to be published under the Health domain is one of the key responsibilities of Samantha. She can craft news pieces on diverse topics including EHR, AI, and IoT in the Health domain and holds strong observation skills.

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © All right reserved. | Theme: Business Click by eVisionThemes